TABLE 2.
Group | Data for day 1
|
Data for day 3
|
||
---|---|---|---|---|
P. gingivalis/ PMNb | % Phagocytosisc | P. gingivalis/ PMN | % Phagocytosis | |
1 | NDd | ND | ND | ND |
2 | 4.81 ± 4.35 | 55.39 ± 42.29 | 3.90 ± 3.68 | 42.41 ± 20.45 |
3 | 0.24 ± 0.19 | 4.33 ± 4.91 | 5.62 ± 7.81 | 37.35 ± 27.93 |
4 | 8.08 ± 7.95 | 59.15 ± 30.45 | 2.82 ± 1.91 | 44.34 ± 17.41 |
5 | 7.12 ± 7.27 | 53.65 ± 39.66 | 5.66 ± 4.20 | 52.32 ± 14.85 |
6 | 14.81 ± 4.5 | 40.79 ± 44.08 | 1.53 ± 1.32 | 30.92 ± 21.94 |
Groups of mice (n = 8 animals per group) were challenged subcutaneously with P. gingivalis, and chamber fluid samples were harvested at 1 and 3 days after challenge. Group 1 received vehicle only, group 2 was challenged with P. gingivalis, group 3 received P. gingivalis-specific IgG injection into the chamber 24 h prior to challenge, group 4 received IRR-IgG injection prior to challenge, group 5 was challenged with P. gingivalis opsonized with P. gingivalis-specific IgG, and group 6 was challenged with IRR-IgG-opsonized P. gingivalis.
P. gingivalis/PMN was determined as the total number of live and dead bacteria present within at least 100 live PMNs.
% Phagocytosis was determined as the number of viable PMNs that have at least one associated bacterium divided by the total number of PMNs counted, all multiplied by 100.
ND, not determined.